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Adhesion of U-937 monocytes induces cytotoxic damage and
subsequent proliferation of cultured human mesangial cells
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Department of Medicine, Division of Nephrology, University "La Sapienza," Rome, Italy
Adhesion of U-937 monocytes induces cytotoxic damage and subse-
quent proliferation of cultured human mesangial cells. In an in vitro
model of monocyte adhesion to glomerular cells, U-937 myelomonocytic
leukemia cells irreversibly bind to human mesangial cell monolayers.
Adhesion is enhanced in mesangial cells proliferating in response to fetal
bovine serum, and in the presence of several cytokines and vasoactive
agents. In the present study, co-culture with U-937 followed by removal of
non-adherent cells time-dependently decreased viability of mesangial
cells, measured either by fluorometry after dual labeling with calcein
acetoxymethylester and ethidium homodimer, or by the release of lactate
dehydrogenase. The cytotoxic effects of co-culture with U-937 cells were
significantly reduced by a combination of free radical scavengers, indicat-
ing involvement of reactive oxygen species. U-937 cells also stimulated
subsequent proliferation of mesangial cells, assessed by [3H]-TdR incor-
poration and direct cell counts 24 hours later (from 1,034 83 to 14,611
959 and from 2,931 201 to 19,400 2,124 cpm/well, quiescent/cycling
mesangial cells, respectively, P < 0.01). Controls to rule out TdR
incorporation by adherent U-937 cells included selective [3H1-TdR label-
ing and demecolcine pretreatment. Cell counts at 24 hours confirmed
U-937-induced proliferation of quiescent HMC, from 50,575 3,596 to
143,012 10,039 cells/cm2 (P < 0.01). Agents that promote U-937 cell
adhesion, such as the TxA2 mimetic, U-46619, or angiotensin II, enhanced
cytotoxicity while inhibiting the proliferation of both quiescent and cycling
mesangial cells, when added during co-culture and the subsequent 24
hours (+1 jsM U-46619, 1,875 131 and 2,546 125 cpm/well, respec-
tively, 79,793 5,744 cells/cm2, P < 0.01 vs. U-937 only; + 1 jsM Ang II,
5066 560 and 5,784 306 cpm/well, respectively, 81,068 4,671
cells/cm2, P < 0.05). Blocking antibodies against the adhesion molecule
ICAM-1 and leukocyte counterreceptors (LFA-1, VLA-4) prevented the
proliferative response, which could not be duplicated with the conditioned
media of U-937 alone or co-cultured with mesangial cells. These findings
may reflect the interactions occurring in vivo between infiltrating leuko-
cytes and resident cells during glomerular inflammation.
Several forms of renal disease are characterized by extensive
mononuclear cell recruitment within the kidney, including gb-
merulonephritis, vasculitis, renal allograft rejection, interstitial
nephritis, and ureteral obstruction [1—51.
Leukocytes play a critical role in the induction of renal lesions,
with subsequent disposal of cell debris and immune deposits,
upon cessation of the initial insult to the kidney [61. A host of
diffusible mediators and enzymes released by leukocytes is likely
to modulate further leukocyte chemoattraction, transcapillary
Received for publication July 25, 1995
and in revised form January 4, 1996
Accepted for publication January 15, 1996
© 1996 by the International Society of Nephrology
migration, and differentiation in situ to serve specialized functions
in the inflammatory process [1—7]. In addition to cytotoxic activity
leading to necrotizing lesions, leukocytes participate in the sub-
sequent reparative process, with reorganization of kidney struc-
tures and/or scarring. Growth factors are typical leukocyte prod-
ucts that are likely to mediate tissue repair and recovery of
structural integrity of the kidney [7].
In an in vitro model of monocyte interaction with resident
glomerular cells, we established that various cytokines and vaso-
active agents modulate the binding of U-937 human myelomono-
cytic leukemia cells to cultured human glomerular mesangial cells
[8, 9]. The reproducible phenotype and behavior of U-937 cells is
well suited to the study of direct interactions occurring in culture
between bone marrow-derived cells and gbomerular cells [8, 9]. In
the present investigation we have assessed the effects of U-937
cells on the viability and growth rates of human mesangial cells, in
the hypothesis that leukocyte chemoattraction translates into
cytotoxic damage and subsequent proliferation of glomerular
cells. Since vasoactive agents that bind to receptors on mesangial
cells modulate their phenotype and increase binding of monocytes
[8—11], we also studied the effects of two structurally unrelated
vasoconstrictors, a thromboxane A2 (TxA2) mimetic/endoperox-
ide analogue, and the vascular octapeptide angiotensin II on
U-937-induced mesangial cell damage and proliferation. In earlier
work on mouse thymocytes, TxA2 receptor activation has been
shown to trigger apoptosis, that is, programmed cell death,
possibly via intracellular Ca2 ([Ca2]) elevation [12]. The results
of our study are consistent with a model by which these com-
pounds regulate leukocyte chemoattraction and subsequent func-
tional responses in mesangial cells, including cell proliferation.
Methods
Cell cultures
Human mesangial cell cultures were established with standard
techniques from glomerular explants [13, 14]. Kidneys not suitable
for transplantation or nephrectomy specimens were used with the
written permission of patients or relatives. Four independent cell
lines characterized according to previously published criteria
[13—15] were employed in passages 2 to 15. Cells were cultured in
RPMI 1640 medium supplemented with 17% fetal bovine serum
(FBS; Flow Laboratories, Irvine, UK), 5 .tg/ml human recombi-
nant insulin (Novo, Copenhagen, Denmark), and 10 .tg/ml ceftri-
axone (Hoffmann-La Roche, Basel, Switzerland).
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Undifferentiated U-937 cells (ATCC code CRL 1593) [8, 9]
were grown in suspension cultures employing the same FBS-
supplemented RPMI 1640 medium. Cultures were expanded by
seeding 2 X 106 cells into 25 ml in 260 ml flasks (Nunclon,
Denmark) every 72 hours. Fresh medium was added every 24
hours. Prior to an experiment, the suspension was centrifuged at
1,000 g for 10 minutes, the cells rinsed once in serum-free RPMI
1640, counted and spun again before final resuspension at the
desired density in the experimental incubation medium.
Adhesion assays
A suspension of undifferentiated U-937 cells (density 2 >< 106
cells/mi) in complete RPMI 1640 medium was layered onto
confluent monolayers of human mesangial cells in 24-well plates
(total volume, 500 jsl/well). After incubation at 37°C for three
hours, chosen on the basis of preliminary time-course experiments
[9], the suspension was aspirated, and non-adherent U-937 cells
were dislodged by rinsing the monolayers three times with sterile
phosphate-buffered saline (PBS, pH 7.3).
Mesangial cell toxicity assays
Cytotoxic injury to mesangial cells was assessed in parallel by a
novel fluorimetric assay based on dual labeling with markers of
viable and dead cells, and by a lactate dehydrogenase (LDH)
release assay.
Fluorimetric assay. Viability of mesangial cells was assessed by
the Live/Dead® Eukolight°° kit (L-3224; Molecular Probes, Eu-
gene, OR, USA). After co-culture with U-937 cells, mesangial cell
monolayers grown on plastic Aclar (Allied Engineered Plastics,
Pottsville, PA, USA) coverslips were loaded for 30 minutes at
37°C with 2 tIM calcein acetoxymethylester, which is concentrated
and retained in viable cells, and stained simultaneously with 4 jIM
ethidium homodimer (EthD-1), which labels nucleic acids in
damaged cells. Fluorescence was detected at 530 and 645 nm,
respectively, with excitation set at 485 nm in a Perkin-Elmer LS5B
fluorimeter. Quadruplicate coverslips were averaged for each
experiment, with readings taken four times on the same coverslip
at 90° angles, in order to control for uneven cell density. Fluores-
cence microphotographs were preliminarly taken on randomly
chosen fields to identify individual cell staining and rule out
damage to adherent U-937 cells. A fluorescein 485 nm excitation
filter and a long-pass 590 nm emission filter installed on a Zeiss
Axioplan microscope were employed.
LDH release assay. LDH was determined spectrophotometri-
cally by a commercial detection kit (Boehringer Mannheim,
Germany) in the supernatant of the co-culture experiments or
control incubations of each cell line. Specific release was calcu-
lated according to the formula:
Specific release =
test sample — spontaneous release
maximum release
Mesangial cell proliferation assays
[3H]-thymidine (TdR) incorporation. Mesangial cell prolifera-
tion was assessed by measuring [3H1-TdR incorporation into
DNA during a three-hour pulse (1 jsCi/ml, specific activity 6.7 Ci
mmol'; Amersham, Milan, Italy) following three-hour co-
culture with 2 X 106 U-937/ml RPMI 1640 medium, removal of
non-adherent cells, 2 x washings, and further 24-hour incubation
of human mesangial cells plus adherent U-937. Control wells were
subjected to the same protocol, using fresh medium without
U-937 cells. Quiescent and proliferating mesangial cells, cultured
for 72 hours prior to the experiment in 0.5 or 17% FBS,
respectively, were employed. At the end of the pulse, the medium
containing excess [3H]-TdR was aspirated, followed by 3 X
washing with PBS, pH 7.3. The monolayers were then dissolved in
1 ml 0.1% SDS, containing 1 mg/mi bovine serum albumin (BSA)
as a carrier protein, and precipitated with 10% TCA (final vol/vol)
for 30 minutes at 4°C. The TCA-precipitable material was then
pelleted by centrifugation at 3000 g for 15 minutes at 4°C,
resuspended in 0.1% SDS, and counted by liquid scintillation
spectrometry.
Since adherent cells might theoretically retain their prolifera-
tive potential, thus incorporating [3HJ-TdR and thereby overesti-
mating mesangial cell labeling, in parallel control experiments the
suspension of U-937 was growth-arrested by overnight preincuba-
tion with 0.3 jIg/mI N-deacetyl-N-methylcolchicine (demecolcine).
After washing 2 X by centrifugatiori and resuspension in deme-
colcine-free, serum-free media, U-937 cells failed to incorporate
[3HJ-TdR during a three-hour pulse, while retaining normal
adhesiveness to a quiescent monolayer of mesangial cells, thus
serving as a control for the mesangial DNA synthesis experiments.
Cell counts. Parallel cell counts were carried out in monolayers
grown in 12-well dishes, and dislodged by mild trypsinization (1
mm 0.05% trypsin/0.02% ethylene diaminotetraacetate in Ca2,
Mg2-free PBS), followed by gentle abrasion with a plastic cell
scraper. Duplicate counts were performed by standard hemocy-
tometry on triplicate wells, averaged and expressed as number of
cells per cm2 of growth surface.
Materials
U-46619 (9,1 1-dideoxy-9a,lla-methanoepoxy-prostaglandin
PGF2) was purchased from Cayman Chemicals (Ann Arbor, MI,
USA). Human recombinant tumor necrosis factor-n was from
Cetus Corp. (Emeryville, CA, USA). Rabbit polyclonal antibodies
neutralizing platelet-derived growth factor AA and BB ho-
modimers were from Biogenesis Ltd. (Poole, UK); blocking
monoclonal antibodies anti-human CD 54 (ICAM-1), CD 106
(VCAM-1), integrin n4, integrins /31 and /32, and CD ha were
purchased from Chemicon International (Temecula, CA, USA).
All other chemicals were of the purest grade available from Sigma
(St. Louis, MO, USA), unless otherwise indicated.
Results
Co-culture of U-937 cells with human mesangial cells resulted
in time-dependent, irreversible adhesion of a variable fraction of
U-937 cells to the underlying mesangial monolayer [9]. No
adhesion occurred to uncoated plasticware under any experimen-
tal condition. Bound U-937 could not be displaced by repeated
washings or prolonged incubation in fresh media or PBS buffer,
most likely because adhesion involved the formation of stable
intercellular adhesion structures or pseudopodia.
To gain an insight into the functional implications of the
interaction between U-937 cells and human mesangial cells, we
screened the mesangial cultures for possible effects on cell
viability. Experiments with the dual calcein/EthD-1 label demon-
strated that viability of mesangial cells, revealed by retention of
calcein and no staining with EthD-1, was significantly impaired by
exposure to U-937 cells (Figs. 1 and 2). The substantial absence of
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Mesangial +U-937 +U-937 Triton
cells +U-46619 X-100
Fig. 1. Effects of U-937 cell adhesion on calcein acetoxymethylester retention
by cultured human mesangial cells after 3-hour co-incubations in the presence
of] j.t.i U-46619 or vehicle. Triton X-100, 0.1% vol/vol, was used as a
positive control for cell damage. % max fluorescence of control, viable
cells SE from N = 8 experiments. *p < 0.05, **p < 0.01 versus untreated
mesangial cells, one-way ANOVA.
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Fig. 2. Effects of U-937 cell adhesion on ethidium hoinodimer (EthD-1)
staining of cultured human mesangial cells after 3-hour co-incubations in the
presence of] p.xi U-46619 or vehicle. Triton X-l00, 0.1% vol/vol, was used
as a positive control for cell damage. % max fluorescence of control, 70%
ethanol-fixed cells SE from N = 8 experiments. < 0.05, **P < 0.01
versus untreated mesangial cells, one-way ANOVA.
EthD-1-positive cells in control mesangial cultures revealed that
the population studied was largely viable. As a positive control for
cell toxicity, Figure 2 illustrates the marked EthD-1 staining of
methanol-killed cells, without relevant calcein retention. Under
no circumstances were U-937 cells seen under fluorescence mi-
croscopy to exclude calcein or label up with EthD-1, indicating
that toxicity was restricted to mesangial cells. Toxicity was time-
dependent, progressively increasing from 3 to 12 hours, to stabi-
lize at 24 hours, when only a minority of mesangial cells retained
calcein (3 hr 67.3 1.6% live cells, 6 hr 55.4 1.5%, 12 hr 36.6
2.6%, 24 hr 39.9 1.7%). Notably, co-culture in the presence
of the TxA2 mimetic U-46619, 1 jx, which we have previously
shown to enhance U-937 adhesion to mesangial cells [91, also
significantly increased the percentage of damaged mesangial cells,
revealed by enhanced red fluorescence and decreased calcein
Table 1. Lactate dehydrogenase (LDH) release by cultured human
mesangial cells co-cultured for 3 hours with U-937 cells
Condition % Specific release
Control mesangial cells 3.1 0.03
Control U-937 8.3 0.9
Mesangial cells + U-937 24.0 2.T'
Mesangial cells + U-937 + 1 M U-46619 397 2.2'
Data are mean SE % specific LDH release at end of 3-hour
incubations.
aP < 0.05 vs. control mesangial cells; b P < 0.05 vs. mesangial cells +
U-937, one-way ANOVA on N = 4 experiments
Table 2. Effects of ROS scavengers (10 iM MESNA, 450 lU/mi
superoxide dismutase, 400 rg/ml catalase) on cytotoxicity of U-937 cells
for cultured human mesangial cells (HMC) during 3-hour co-cultures
HMC + U-937
HMC + U-937 + ROS scavengers
% Live cells (calcein — AM)
% Dead cells (EthD-1)
49.7 2.5
48.2 5.2
85.5 4.P
19.8 1.8
% Live or dead cells calculated as measured fluorescence — minimum
fluorescence/maximum fluorescence minimum fluorescence at 530 nm
(calcein) or 645 nm (EthD-l) emission wavelengths.
aP < 0.05 vs. HMC + U-937 by one-way ANOVA from N = 8
experiments
staining (Figs. I and 2). In previous studies, we have shown that
identical concentrations of U-46619 have no intrinsic toxicity for
cultured mesangial cells [15]. Separate treatment of U-937 cells
with U-46619 for three hours prior to the standard three-hour
co-cultures yielded a degree of cell damage comparable to that
observed when the compound was present only during co-culture
(1 J.tM U-46619 during co-culture without pretreatment, 57.6
1.7% live cells; selective pretreatment of U-937 with U-46619,
58.0 2.4%, P = NS). Separate U-46619 pretreatment of
mesangial cells prior to co-culture failed to promote toxicity (75.5
4.7% live cells, P < 0.05 vs. U-46619 during co-culture). The
fluorescence studies were validated by measurement of actual
LDH release, which also confirmed substantial damage of mes-
angial cells during co-culture (Table 1). Again, U-46619 enhanced
toxicity with a pattern similar to that revealed by vital fluorescence
staining.
To understand the potential mechanisms of cytotoxicity in the
absence of any complement in the incubation media, we repeated
the experiments in the presence of a mixture of free radical
scavengers, currently employed to neutralize the generation of
reactive oxygen species (ROS) in various cell systems. 2-Mercap-
toethanesulfonic acid (MESNA, 10 fLM), 450 IU/ml superoxide
dismutase, and 400 xg/ml catalase significantly prevented the
uptake of EthD-1 and increased calcein retention (Table 2), thus
suggesting that a major component of the injuiy to mesangial cells
was actually due to the release of ROS at the site of cell-to-cell
interaction. Again, the two fluorescent tracers provided nearly
symmetrical data, confirming their usefulness for vital staining
studies.
Based on the cytotoxicity studies, we searched for possible
effects of U-937 cells on subsequent proliferation of residual
mesangial cells, which could result from breaking contact inhibi-
tion of confluent monolayers, and/or from the release of diffusible
mediators. As shown in Figures 3 and 4, application of U-937 cells
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Fig. 3. Effects of 3-hour coincubation with U-937 cells on subsequent
proliferation of quiescent cultured human mesangial cells. [3H1-TdR labeling
of human mesangial cells for three hours after removal of non-adherent
cells and further 24-hour incubation. Note inhibition of proliferation by 1
/LM U-46619 and 1 /LM angiotensin II (Ang II). < 0.01 versus quiescent
mesangial ccli control (MC); ** < 0.01 versus mesangial cells coincu-
bated with U-937 cells, one-way ANOVA on N = 8 experiments.
Fig. 4. Effects of 3-hour coincubation with U-937 cells on proliferation of
quiescent cultured human mesangial cells. Total cell counts upon mild
trypsinization of monolayers, following removal of non-adherent cells and
further 24-hour incubation. Note inhibition of proliferation by I M
U-46619 and 1 LM angiotensin II (Ang IT). < 0.05 versus quiescent
mesangial cell control (MC); P < 0.05 versus mesangial cells coincu-
bated with U-937 cells, one-way ANOVA on N 8 experiments.
to quiescent monolayers of human mesangial cells, and subse-
quent co-culture for 24 hours after removal of non-adherent
monocytes, led to a significant increase of mesangial DNA
synthesis and cell number. Similar results were obtained when
actively cycling mesangial cells, maintained in the presence of
17% FBS, were used (Fig. 5). Such response could not be
attributed to incorporation of [3H]-TdR by U-937 cells, which
remained vital throughout the co-culture, since: (i) U-937 were
not counted in the cell number studies, as their smaller volume
Fig. 5. Effects of 3-hour coincubation with U-937 cells on proliferation of
serum-treated cultured human mesangial cells. [1HJ-TdR labeling of human
mesangial cells for three hours after removal of non-adherent cells and
further 24-hour incubation, 17% fetal bovine serum present throughout.
Note the inhibition of proliferation by 1 jLM U-46619 and 1 sM angiotensin
II (Ang TI). *p < 0.01 versus control mesangial cells (MC); ** < 0.01
versus mesangial cells eoincubated w/U-937 cells, one-way ANOVA on
N = 8 experiments.
Fig. 6. Effects of 3-hour coincubation with 0.3 uglml demecolcine-treated
U-937 cells on proliferation of quiescent (-FBS, i21) or serum-stimulated
(+FBS, U) cultured human mesangial cells. [3H}-TdR labeling of human
mesangial cells for three hours after removal of non-adherent cells and
further 24-hour incubation. *J) < 0.05, P < 0.01 versus control
mesangial cells (MC) identically treated in the absence of U-937 cells,
one-way ANOVA on N = 4 experiments.
was easily distinguishable from the over 10-fold larger mesangial
cells, (ii) their total number was lower than mesangial cells in
monolayer culture, and therefore (iii) their absolute [3HJ-TdR
incorporation, when assessed by selective labeling of U-937 prior
to co-culture, was sensibly lower than that of mesangial cells at the
end of an experiment (U-937 alone 728 18 cpm/well; U-937 +
mesangial cells 3991 465 cpm/well, P < 0.05). Moreover, we
carried out studies with demecolcine-treated U-937 cells, in which
DNA synthesis was selectively prevented by the cytostatic agent,
which arrests the cell cycle in metaphase. These studies, illustrated
in Figure 6, provide further evidence that monocyte uptake of
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Condition
[3H]-TdR incorporation
cpm/well
Control 1,267 440
+ Conditioned media from U-937 cultures 1,204 353
+ TNF-a 1,427 530
+ U-46619 1,338 446
+ Conditioned media from U-937/ 1,342 410
mesangial cell co-cultures
17% FBS 10,464 891
Data are mean SE [3Hj-TdR labeling after 24-hour incubation with
conditioned medium from co-cultures or pure U-937 cultures stimulated
for 48 hrs with 100 ng/ml tumor necrosis factor-a (TNF-a) or 1 jLM
U-46619. 17% fetal bovine serum (FBS)-stimulated proliferation is shown
as positive control.
aP < 0.01 vs. control mesangial cells, one-way ANOVA on N = 8
experiments
[3H]-TdR does not account for the markedly increased DNA
synthesis observed in the co-cultures, since even metaphase-
blocked U-937 provoked significant increments of DNA synthesis,
which must therefore be occurring in mesangial cells only.
Figures 3, 4 and 5 also illustrate the growth inhibitory activity of
1 fLM U-46619 and another stimulus of mesangial cell phospho-
lipase C/cytosolic free Ca2, 1 j.tM Ang II, added during the
coincubation of U-937 cells and mesangial cells. Notably, U-46619
completely reversed the effects of U-937 cells on either quiescent
or proliferating mesangial cells, while Ang II had lower, yet
significant, antiproliferative potency. In either case, the effect
should be attributed solely to activation of mesangial cell recep-
tors for these agents, since U-937 cells do not express such
phospholipase C- or A2-coupled receptors, as indicated by lack of
elevation of cytosolic free Ca2 and PG synthesis, respectively,
upon addition of the vasoactive substances (not shown).
To establish whether stimulation of proliferation is the result of
the release of a stable growth factor into the culture media, or
rather of the direct interaction of monocytes with the plasma
membrane of mesangial cells, we performed media cross-ex-
change experiments, in which mesangial cells were exposed for 24
hours to the conditioned medium of separate U-937 cell cultures
or U-937/mesangial cell co-cultures diluted 1:1 with fresh RPMI
1640 medium. In addition, stimuli of monocyte adhesion to
human mesangial cells, such as U-46619 and tumor necrosis
factor-a [9, 11], were also used in other groups of experiments.
Table 3 shows the lack of effect of all conditioned media on
human mesangial cell proliferation, implying either that a direct
interaction is required for the mitogenic effects of U-937 cells, or
that a labile mediator needs to be continuously released during
co-culture. Normal responsiveness of mesangial cells in parallel
experiments was demonstrated by the marked proliferative effect
of 17% FBS, added to the conditioned media (Table 3).
To further elucidate the mechanism(s) leading to mesangial cell
proliferation, we performed the co-cultures in the presence of a
series of blocking antibodies for a host of adhesion molecules and
their leukocyte counterreceptors, previously shown to mediate
cell-to-cell interactions in this and similar experimental systems
[9—111. These studies, summarized in Figure 7, clearly show that
displacing recognition of certain adhesion molecules, namely
ICAM-1 and its leukocyte counterreceptor complex of integrins
LIitIi
I I
Fig. 7. Effects of blocking antibodies (Ab) on U-93 7-stimulated proliferation
of quiescent cultured human mesangial cells. At the end of 3-hour co-
cultures, non-adherent cells were removed and mesangial cells were
further incubated for 24 hours, followed by labeling with 1 j.Ci/ml
[3H}-TdR for three hours. Antibodies against platelet-derived growth
factor (PDGF) homodimers AA and BB (10 jLglml), intercellular adhe-
sion molecule-i (ICAM-i), vascular cell adhesion molecule-i (VCAM-1),
VLA-4, CD ha, and LFA-1 (5 jgJml) added two hours before U-937 and
present throughout co-culture + subsequent incubation (I). MC is the
control mesangial cells, which were identically treated in the absence of
U-937. *p < 0.05, < 0.01 versus mesangial cells + U-937 without Ab,
one-way ANOVA on N = 4 experiments.
CD11a/CD18, LFA-1 [101, blunts subsequent proliferation of
mesangial cells. Notably, leukocyte VLA-4, but not its mesangial
cell ligand VCAM-1, also plays a role in the proliferative re-
sponse. As a control for the possible non-specific antiproliferative
effects of blocking antibodies, we also employed anti-platelet-
derived growth factor (PDGF) antisera. Neutralization of PDGF-
BB, the most potent mitogen for mesangial cells, failed to affect
growth of the cells, consistent with previous evidence from the
media cross-exchange experiments that peptide mitogens are
unlikely to be involved in the proliferative events observed.
Predictably, antibodies towards the PDGF-AA homodimer, pro-
duced by mesangial cells, but scarcely active due to lack of the a
receptors, had again no antiproliferative effect. This indicates the
specificity of the signalling mechanisms triggered by adhesion
molecule recognition, and mediating the physical interaction
between leukocytes and mesangial cells.
Discussion
We have recently adapted a stable, well-characterized line of
human myelomonocytes, the U-937 cells, to the study of mono-
nuclear cell adhesion to and activation by kidney cells [8, 91. These
cells, layered in co-culture with syngeneic mesangial cells, behave
similarly to freshly isolated peripheral blood monocytes [91,
adhering to the underlying monolayer in a time-dependent,
irreversible fashion, and triggering cytotoxic cell damage followed
by later proliferation. Mesangial toxicity of leukocytes is not
unprecedented, as demonstrated by earlier studies with peripheral
blood monocytes/mesangial cell co-cultures, and by evidence of
"mesangiolysis" or even apoptosis-programmed cell death in
immune-mediated glomerular inflammation [6, 10, 11, 161. As to
the cellular mechanisms of this toxic effect, our techniques
Table 3. Lack of effect of U-937 cell-conditioned media on
proliferation of quiescent cultured human mesangial cells C
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provide initial evidence for a direct, cell-mediated type of injury,
involving the release of ROS. This is not surprising in leukocyte-
mediated, direct cytotoxicity. Clearly, other mechanisms, such as
toxic cytokines or pore-forming membrane ligands, cannot be
excluded [5, 17].
Following the onset of mesangial damage, a proliferative re-
sponse ensues, which is selective for the mesangial cell, detectable
both in quiescent and serum-stimulated cultures, and independent
of stable growth factors released into the culture media. Our
experiments rule out the possibility that proliferation attributed to
mesangial cells was an artifact due to [3H]-incorporation by the
actively proliferating U-937 cells, since direct cell counts easily
discriminate between small, mononuclear U-937 cells and larger,
smooth muscle-like mesangial cells. Moreover, U-937 cells ren-
dered quiescent by pretreatment with demecolcine had identical
effects on subsequent [3H]-TdR incorporation following co-cul-
ture, thus indicating that proliferation indeed occurred solely
within the mesangial cell population. The state of quiescence or
proliferation of mesangial cells did not influence the response, as
nearly identical increments of the growth rates were observed
when serum-deprived or serum-stimulated cultures were em-
ployed. The lack of effect of conditioned media, and failure to
block proliferation with anti-PDGF antibodies, indicated that a
stable mitogen, such as most peptide growth factors, is unlikely to
be involved. Rather, a labile agent, possibly diffusible at sites of
cell-to-cell contact, could be responsible for the observed prolif-
erative response. Obviously, other mechanisms could be impli-
cated, including mesangial cell damage and death, with subse-
quent loss of contact inhibition and "reparative" proliferation,
aimed at restoring continuity of the monolayer. This may well be
the case, based on the cell toxicity experiments, in which rather
extensive mesangial cell injury was brought about by the simple
adhesion of U-937 cells for three hours. The discrepancy between
stimulation of proliferation by U-937 alone and inhibition of
proliferation observed when the monolayer was activated by
vasoconstrictors, that is, U-46619 and Ang II, may be possibly
explained by a greater degree of cell toxicity upon adhesion of a
larger fraction of monocytes. More extensive mesangial cell loss
over long-term incubations, that is, 24 hours + three hours
labeling with [3H]-TdR, may result in actual offsetting of the
proliferative effects. Alternatively, it should be considered that
previous studies from our and other laboratories have shown
inhibition of serum-stimulated proliferation by stimuli of phos-
pholipase C or other cytokines [18—20]. This is the case for the
TxA2 mimetic, U-46619, which has weak mitogenic effects on
quiescent cells, but inhibits proliferation stimulated by serum or
purified growth factors [19]. Related compounds promote apo-
ptosis of mouse immature thymocytes via a mechanism involving
elevation of [Ca2] [12]. Since TxA2 mimetics elicit similar
intracellular signals in mesangial cells [15, 19, 21], the possible
occurrence of apoptosis should be examined as a possible expla-
nation for long-term inhibition of growth. Thus, the present
findings point to a critical role of vasoconstrictor agents, released
either by infiltrating cells, such as TxA2, or by activated endothe-
hal cells, as in the case of Ang II, in the modulation of leukocyte
transmigration and participation in the inflammatory process [17,
22].
The importance of the mesangial proliferative effects of mono-
cytes is severalfold: first, non-differentiated monocytes modulate
the growth behavior of cultured glomerular cells, implying that
migration of leukocytes into the glomerulus may be responsible
for cellular proliferation in vivo; second, adhesion of monocytes
and their possible differentiation in situ may regulate other
functions of renal cells, including the local control of glomerular
hemodynamics; third, manipulation of the monocyte chemoattrac-
tant and adhesive properties may translate into functional changes
of glomerular cells, which are believed to represent the ultimate
causes of scarring and sclerosis in a variety of chronic glomerular
diseases [23, 24].
The structures that underlie recognition of glomerular cells and
subsequent adhesion of monocytes are surface molecules, such as
ICAM-1 or VCAM-1, along with mesangial matrix components
[16, 25—28]. Several studies, including ours with U-937 cells, have
described the facilitating role of cytokines and vasoactive agents
on monocyte adhesion to mesangial cells, possibly mediated by
overexpression of adhesion molecules [9—11, 16]. Recent work has
related the distribution and regulation of adhesion molecules with
the pathogenesis of glomerulonephritis [29 —32], whose course has
also beeen experimentally modified by manipulation of such
surface determinants [29]. It remains to be established whether
interaction of mesangial cell adhesion molecules with their leu-
kocyte counterreceptors may represent a signal for subsequent
cellular events such as apoptosis and proliferation of surviving
cells. Our experiments with blocking antibodies towards ICAM-1
and LFA-1/VLA-4, which antagonize U-937 cell adhesion [91, and
inhibit proliferation, are consistent with this possibility. It is also
unclear whether the phenotype of mesangial cells may be altered
in the direction of matrix or extracellular protein synthesis by
monocyte adhesion. This would account for the matrix-forming
potential of these cells, which are known to functionally behave as
"myofibroblasts," that is, multipotent cells whose phenotype in
vitro and in vivo is regulated by the surrounding microenviron-
ment [33, 34].
In conclusion, regulation of monocyte adhesion by cytokines
and vasoactive agents underscores the role of diffusible mediators
in the recruitment of leukocytes and amplification of inflamma-
tion in glomerulonephritis and renal interstitial disease. The
understanding of the mechanisms mediating these cellular inter-
actions may lead to novel insights into the pathogenesis and
treatment of nephritides with leukocyte infiltration.
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